Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up. Background: Neoadjuvant chemotherapy with anthracycline and taxane combinations is ...
Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse Patients were eligible if they had stage I to III operable ...
September 16, 2008 (Stockholm, Sweden) — The addition of docetaxel (Taxotere, Sanofi Aventis) to a traditional anthracycline-based regimen significantly improved both relapse-free survival and overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results